Article Figures & Data
Figures
- Figure 1.
Matrix-producing breast carcinoma imaging findings. A: Breast ultrasound sonogram showed a lobulated hypoechoic mass that was well-defined with a rough border and heterogeneous echo in internal structure. B: Contrast-enhanced computed tomography revealed a peripheral ring enhancement (arrow) in the breast tumor. C: Contrast-enhanced T2-weighted magnetic resonance imaging showed a ring-enhanced appearance in the tumor (arrow).
- Figure 2.
Matrix-producing breast carcinoma microscopic findings (hematoxylin and eosin staining). A: The tumor was relatively well-circumscribed, and viable cancer cells were located on the periphery (arrows) (×20). B: Invasive carcinoma, with trabecular cell nests, was seen, and a chondromyxoid matrix was attached (arrows) (×100).
- Figure 3.
Metastatic carcinoma of the ovary. A: The right ovary was enlarged and was totally replaced by metastatic tumor (arrows) (hematoxylin and eosin staining, ×20). B: The tumor histology was consistent with metastatic breast carcinoma (arrows)(hematoxylin and eosin staining, ×200). C: Programmed cell-death ligand 1 (PD-L1; clone SP142; ×400) staining was positive for tumor-infiltrating immune cells (black stain).
- Figure 4.
Computed tomography images before (A, B) and after (C, D) eribulin therapy. A rapid enlargement of the thyroid gland (red arrows) and cervical (yellow arrows) and mediastinal lymph nodes (blue arrows) was observed after eribulin therapy.
